Kymera Therapeutics Inc
(NASDAQ:KYMR)
$13.90
-0.40[-2.80%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$13.90
0[0.00%]
Open14.430Close13.900
Vol / Avg.754.422K / 375.586KMkt Cap770.231M
Day Range13.850 - 14.54052 Wk Range14.200 - 39.850

Kymera Therapeutics Stock (NASDAQ:KYMR) Earnings Dates and Earning Calls

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.730

Quarterly Revenue Estimate

$21M

Annual Revenue (as of Jun 30)

$51.7M

Earnings History

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.67, which beat the estimate of $-0.71.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $16.5M, which beat the estimate of $14.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Kymera Therapeutics Stock (NASDAQ:KYMR) Earnings Dates and Earning Calls

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.730

Quarterly Revenue Estimate

$21M

Annual Revenue (as of Jun 30)

$51.7M

Earnings History

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.67, which beat the estimate of $-0.71.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $16.5M, which beat the estimate of $14.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Kymera Therapeutics Stock (NASDAQ:KYMR) Earnings Dates and Earning Calls

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.730

Quarterly Revenue Estimate

$21M

Annual Revenue (as of Jun 30)

$51.7M

Earnings History

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.67, which beat the estimate of $-0.71.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $16.5M, which beat the estimate of $14.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Kymera Therapeutics Stock (NASDAQ:KYMR) Earnings Dates and Earning Calls

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.730

Quarterly Revenue Estimate

$21M

Annual Revenue (as of Jun 30)

$51.7M

Earnings History

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.67, which beat the estimate of $-0.71.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $16.5M, which beat the estimate of $14.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Kymera Therapeutics Stock (NASDAQ:KYMR) Earnings Dates and Earning Calls

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.730

Quarterly Revenue Estimate

$21M

Annual Revenue (as of Jun 30)

$51.7M

Earnings History

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.67, which beat the estimate of $-0.71.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $16.5M, which beat the estimate of $14.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Kymera Therapeutics Stock (NASDAQ:KYMR) Earnings Dates and Earning Calls

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.730

Quarterly Revenue Estimate

$21M

Annual Revenue (as of Jun 30)

$51.7M

Earnings History

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.67, which beat the estimate of $-0.71.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $16.5M, which beat the estimate of $14.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Kymera Therapeutics Stock (NASDAQ:KYMR) Earnings Dates and Earning Calls

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.730

Quarterly Revenue Estimate

$21M

Annual Revenue (as of Jun 30)

$51.7M

Earnings History

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.67, which beat the estimate of $-0.71.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $16.5M, which beat the estimate of $14.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Kymera Therapeutics Stock (NASDAQ:KYMR) Earnings Dates and Earning Calls

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.730

Quarterly Revenue Estimate

$21M

Annual Revenue (as of Jun 30)

$51.7M

Earnings History

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.67, which beat the estimate of $-0.71.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $16.5M, which beat the estimate of $14.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Kymera Therapeutics Stock (NASDAQ:KYMR) Earnings Dates and Earning Calls

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.730

Quarterly Revenue Estimate

$21M

Annual Revenue (as of Jun 30)

$51.7M

Earnings History

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.67, which beat the estimate of $-0.71.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $16.5M, which beat the estimate of $14.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2023 Benzinga | All Rights Reserved